As India marks World Liver Day, health experts are raising concerns over the rising burden of liver cancer, a disease often ...

Liver cancer can arise spontaneously from healthy liver tissue. Recently, however, researchers have discovered an increasing ...

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. Multiple treatment modalities ...

Patients who are not eligible for surgical resection may or may not be eligible for liver transplant, depending on the extent ...

Statins appeared to reduce the risk for hepatocellular carcinoma and hepatic decompensation among patients with chronic liver ...

The combination therapy can be used as first-line treatment for unresectable or metastatic forms of the cancer.

The following is a summary of "Epigenetic-modification associated hnRNPA3 acts as a prognostic biomarker and promotes malignant progression of HCC," published in the April 2025 issue of BMC Cancer by ...

The U.S. Food and Drug Administration has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment for ...

The Food and Drug Administration (FDA) has approved Opdivo ® (nivolumab) in combination with Yervoy ® (ipilimumab) for the first-line treatment of adult patients with unresectable or metastatic ...

LIVER cancer is the fourth most common cancer in Malaysia and also the fourth leading cause of cancer-related deaths.

The FDA will allow a trial of gene-edited pig livers as a dialysis-like treatment for people with sudden liver failure. (AP) ...